Advertisement

Neurocritical Care

, Volume 30, Issue 2, pp 364–371 | Cite as

Intraosseous Administration of 23.4% NaCl for Treatment of Intracranial Hypertension

  • Jing Wang
  • Yun Fang
  • Subhashini Ramesh
  • Asma Zakaria
  • Maryann T. Putman
  • Dan Dinescu
  • James Paik
  • Romergryko G. Geocadin
  • Pouya Tahsili-Fahadan
  • Laith R. AltaweelEmail author
Original Article

Abstract

Background/objective

Prompt treatment of acute intracranial hypertension is vital to preserving neurological function and frequently includes administration of 23.4% NaCl. However, 23.4% NaCl administration requires central venous catheterization that can delay treatment. Intraosseous catheterization is an alternative route of venous access that may result in more rapid administration of 23.4% NaCl.

Methods

Single-center retrospective analysis of 76 consecutive patients, between January 2015 and January 2018, with clinical signs of intracranial hypertension received 23.4% NaCl through either central venous catheter or intraosseous access.

Results

Intraosseous cannulation was successful on the first attempt in 97% of patients. No immediate untoward effects were seen with intraosseous cannulation. Time to treatment with 23.4% NaCl was significantly shorter in patients with intraosseous access compared to central venous catheter (p < 0.0001).

Conclusions

Intraosseous cannulation resulted in more rapid administration of 23.4% NaCl with no immediate serious complications. Further investigations to identify the clinical benefits and safety of hypertonic medication administration via intraosseous cannulation are warranted.

Keywords

Intraosseous cannulation Central venous catheter Intracranial hypertension Brain herniation Hypertonic saline 

Notes

Acknowledgement

The authors gratefully acknowledge the clinical support from all the nursing staff at the Emergency Department and Neuroscience Intensive Care Unit of Inova Fairfax hospital, as well as Ann K Aizon and Tricia Brannon, Clinical Research Coordinators from Department of Research, Inova Neurosciences, for their unconditional support.

Authors Contribution

JW and LA were involved in study concept and design. All authors contributed to acquisition, analysis, and interpretation of data. YF and JP contributed to statistical analysis. JW, LA, and PT-F were involved in drafting of the manuscript

Source of Support

This study was not funded.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.

References

  1. 1.
    Andrews BT, Pitts LH. Functional recovery after traumatic transtentorial herniation. Neurosurgery. 1991;29(2):227–31.Google Scholar
  2. 2.
    Skoglund TS, Nellgård B. Long-time outcome after transient transtentorial herniation in patients with traumatic brain injury. Acta Anaesthesiol Scand. 2005;49(3):337–40.Google Scholar
  3. 3.
    Qureshi AI, Geocadin RG, Suarez JI, Ulatowski JA. Long-term outcome after medical reversal of transtentorial herniation in patients with supratentorial mass lesions. Crit Care Med. 2000;28(5):1556–64.Google Scholar
  4. 4.
    Koenig MA, Bryan M, Lewin JL 3rd, Mirski MA, Geocadin RG, Stevens RD. Reversal of transtentorial herniation with hypertonic saline. Neurology. 2008;70(13):1023–9.Google Scholar
  5. 5.
    Seelig JM, Greenberg RP, Becker DP, Miller JD, Choi SC. Reversible brain-stem dysfunction following acute traumatic subdural hematoma: a clinical and electrophysiological study. J Neurosurg. 1981;55(4):516–23.Google Scholar
  6. 6.
    Stevens RD, Shoykhet M, Cadena R. Emergency neurological life support: intracranial hypertension and herniation. Neurocrit Care. 2015;23(Suppl 2):S76–82.Google Scholar
  7. 7.
    Farahvar A, Gerber LM, Chiu Y-L, et al. Response to intracranial hypertension treatment as a predictor of death in patients with severe traumatic brain injury. J Neurosurg. 2011;114(5):1471–8.Google Scholar
  8. 8.
    Carney N, Totten AM, O’Reilly C, et al. Guidelines for the management of severe traumatic brain injury, fourth edition. Neurosurgery. 2017;80(1):6–15.Google Scholar
  9. 9.
    Tyagi R, Donaldson K, Loftus CM, Jallo J. Hypertonic saline: a clinical review. Neurosurg Rev. 2007;30(4):277–89 discussion 289–90.Google Scholar
  10. 10.
    Hays AN, Lazaridis C, Neyens R, Nicholas J, Gay S, Chalela JA. Osmotherapy: use among neurointensivists. Neurocrit Care. 2011;14(2):222–8.Google Scholar
  11. 11.
    Schwarz S, Georgiadis D, Aschoff A, Schwab S. Effects of hypertonic (10%) saline in patients with raised intracranial pressure after stroke. Stroke. 2002;33(1):136–40.Google Scholar
  12. 12.
    Schwarz S, Schwab S, Bertram M, Aschoff A, Hacke W. Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke. Stroke. 1998;29(8):1550–5.Google Scholar
  13. 13.
    Lazaridis C, Neyens R, Bodle J, DeSantis SM. High-osmolarity saline in neurocritical care: systematic review and meta-analysis. Crit Care Med. 2013;41(5):1353–60.Google Scholar
  14. 14.
    Al-Benna S, O’Boyle C, Holley J. Extravasation injuries in adults. ISRN Dermatol. 2013;2013:856541.Google Scholar
  15. 15.
    Zimmet SE. The prevention of cutaneous necrosis following extravasation of hypertonic saline and sodium tetradecyl sulfate. J Dermatol Surg Oncol. 1993;19(7):641–6.Google Scholar
  16. 16.
    Worthington-Kirsch RL. Injection sclerotherapy. Semin Intervent Radiol. 2005;22(3):209–17.Google Scholar
  17. 17.
    McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J Med. 2003;348(12):1123–33.Google Scholar
  18. 18.
    Petitpas F, Guenezan J, Vendeuvre T, Scepi M, Oriot D, Mimoz O. Use of intra-osseous access in adults: a systematic review. Crit Care. 2016;20:102.Google Scholar
  19. 19.
    Lee PMJ, Lee C, Rattner P, Wu X, Gershengorn H, Acquah S. Intraosseous versus central venous catheter utilization and performance during inpatient medical emergencies. Crit Care Med. 2015;43(6):1233–8.Google Scholar
  20. 20.
    Leidel BA, Kirchhoff C, Bogner V, et al. Is the intraosseous access route fast and efficacious compared to conventional central venous catheterization in adult patients under resuscitation in the emergency department? a prospective observational pilot study. Patient Saf Surg. 2009;3(1):24.Google Scholar
  21. 21.
    Leidel BA, Kirchhoff C, Bogner V, Braunstein V, Biberthaler P, Kanz K-G. Comparison of intraosseous versus central venous vascular access in adults under resuscitation in the emergency department with inaccessible peripheral veins. Resuscitation. 2012;83(1):40–5.Google Scholar
  22. 22.
    Ziai WC, Chandolu S, Geocadin RG. Cerebral herniation associated with central venous catheter insertion: risk assessment. J Crit Care. 2013;28(2):189–95.Google Scholar
  23. 23.
    Greenstein YY, Koenig SJ, Mayo PH, Narasimhan M. A serious adult intraosseous catheter complication and review of the literature. Crit Care Med. 2016;44(9):e904–9.Google Scholar
  24. 24.
    Paramedic KR, Lockwood C, Grantham H. First attempt success using intraosseous (IO) as an alternative to intravenous (IV) vascular access in out of hospital cardiac arrest (OHCA): a systematic review. JBI Libr Syst Rev. 2012;10(56 Suppl):1–12.Google Scholar
  25. 25.
    Chesnut RM, Temkin N, Carney N, et al. A trial of intracranial-pressure monitoring in traumatic brain injury. N Engl J Med. 2012;367(26):2471–81.Google Scholar
  26. 26.
    Morris GF, Juul N, Marshall SB, Benedict B, Marshall LF. Neurological deterioration as a potential alternative endpoint in human clinical trials of experimental pharmacological agents for treatment of severe traumatic brain injuries. Executive committee of the international selfotel trial. Neurosurgery. 1998;43(6):1369–72 discussion 1372–4.Google Scholar
  27. 27.
    Clark A, Clarke TNS, Gregson B, Hooker PNA, Chambers IR. Variability in pupil size estimation. Emerg Med J. 2006;23(6):440–1.Google Scholar
  28. 28.
    Kerr RG, Bacon AM, Baker LL, et al. Underestimation of pupil size by critical care and neurosurgical nurses. Am J Crit Care. 2016;25(3):213–9.Google Scholar
  29. 29.
    Qureshi AI, Suarez JI. More evidence supporting a “brain code” protocol for reversal of transtentorial herniation. Neurology. 2008;70(13):990–1.Google Scholar
  30. 30.
    Bourdeaux C, Brown J. Sodium bicarbonate lowers intracranial pressure after traumatic brain injury. Neurocrit Care. 2010;13(1):24–8.Google Scholar
  31. 31.
    Bourdeaux CP, Brown JM. Randomized controlled trial comparing the effect of 8.4% sodium bicarbonate and 5% sodium chloride on raised intracranial pressure after traumatic brain injury. Neurocrit Care. 2011;15(1):42–5.Google Scholar
  32. 32.
    Zeiler FA, Sader N, West M, Gillman LM. Sodium bicarbonate for control of ICP: a systematic review. J Neurosurg Anesthesiol. 2018.  https://doi.org/10.1097/ANA.0000000000000373.Google Scholar
  33. 33.
    Rajajee V, Vanaman M, Fletcher JJ, Jacobs TL. Optic nerve ultrasound for the detection of raised intracranial pressure. Neurocrit Care. 2011;15(3):506–15.Google Scholar
  34. 34.
    Kimberly HH, Shah S, Marill K, Noble V. Correlation of optic nerve sheath diameter with direct measurement of intracranial pressure. Acad Emerg Med. 2008;15(2):201–4.Google Scholar
  35. 35.
    Suarez JI, Qureshi AI, Bhardwaj A, et al. Treatment of refractory intracranial hypertension with 23.4% saline. Crit Care Med. 1998;26(6):1118–22.Google Scholar
  36. 36.
    Surani S, Lockwood G, Macias MY, Guntupalli B, Varon J. Hypertonic saline in elevated intracranial pressure: past, present, and future. J Intensive Care Med. 2015;30(1):8–12.Google Scholar
  37. 37.
    Dolister M, Miller S, Borron S, et al. Intraosseous vascular access is safe, effective and costs less than central venous catheters for patients in the hospital setting. J Vasc Access. 2013;14(3):216–24.Google Scholar
  38. 38.
    Cadena R, Shoykhet M, Ratcliff JJ. Emergency neurological life support: intracranial hypertension and herniation. Neurocrit Care. 2017;27(Suppl 1):82–8.Google Scholar
  39. 39.
    Goldman MP, Kaplan RP, Oki LN, Bennett RG, Strick RA. Extravascular effects of sclerosants in rabbit skin: a clinical and histologic examination. J Dermatol Surg Oncol. 1986;12(10):1085–8.Google Scholar
  40. 40.
    Xie F, Hou K-D, Song Q, Jiang C-G. The change in bone marrow after intraosseous hypertonic saline-hydroxyethyl starch infusion for resuscitation of hemorrhagic shock in dog. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2010;22(5):309–12.Google Scholar
  41. 41.
    Alam HB, Punzalan CM, Koustova E, Bowyer MW, Rhee P. Hypertonic saline: intraosseous infusion causes myonecrosis in a dehydrated swine model of uncontrolled hemorrhagic shock. J Trauma. 2002;52(1):18–25.Google Scholar
  42. 42.
    Duffy DM. Sclerosants: a comparative review. Dermatol Surg. 2010;36(Suppl 2):1010–25.Google Scholar
  43. 43.
    Reades R, Studnek JR, Garrett JS, Vandeventer S, Blackwell T. Comparison of first-attempt success between tibial and humeral intraosseous insertions during out-of-hospital cardiac arrest. Prehosp Emerg Care. 2011;15(2):278–81.Google Scholar
  44. 44.
    Kien ND, Kramer GC, White DA. Acute hypotension caused by rapid hypertonic saline infusion in anesthetized dogs. Anesth Analg. 1991;73(5):597–602.Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature and Neurocritical Care Society 2018

Authors and Affiliations

  • Jing Wang
    • 1
  • Yun Fang
    • 1
  • Subhashini Ramesh
    • 1
  • Asma Zakaria
    • 1
  • Maryann T. Putman
    • 1
  • Dan Dinescu
    • 1
  • James Paik
    • 1
  • Romergryko G. Geocadin
    • 2
  • Pouya Tahsili-Fahadan
    • 1
    • 2
  • Laith R. Altaweel
    • 1
    • 3
    Email author
  1. 1.Neuroscience Intensive Care Unit, Medical Critical Care Service, Department of MedicineINOVA Fairfax HospitalFalls ChurchUSA
  2. 2.Neurocritical Care Unit Division, Department of NeurologyJohns Hopkins UniversityBaltimoreUSA
  3. 3.Neuroscience Research, Neuroscience and Spine InstituteINOVA Fairfax HospitalFalls ChurchUSA

Personalised recommendations